Elevance Health, Inc. Annual Report, Year Ended Dec 31, 2020

Elevance Health, Inc. (formerly Anthem Inc.) reported strong operational and financial performance for the fiscal year ending December 31, 2020. The company demonstrated robust revenue growth, driven by expansion in its Government Business segment (Medicare and Medicaid) and the successful integration of its Pharmacy Benefit Manager (PBM) services through IngenioRx. Despite the challenges posed by the COVID-19 pandemic, Elevance Health maintained a solid membership base, particularly in its government programs, benefiting from increased eligibility and utilization. The company's strategic diversification into integrated health services, highlighted by the acquisition of Beacon Health Options, is progressing well and is expected to contribute to long-term growth. Financially, the company reported total revenues of $121.9 billion, with net income of $4.6 billion. While facing increased COVID-19 related expenses, including testing and treatment, the company managed its benefit expense ratio effectively, partly due to reduced utilization of non-COVID-19 services. Elevance Health also actively managed its capital through share repurchases and dividend payments, reflecting a commitment to shareholder value. The company's balance sheet remains strong, with significant cash and investments, supporting its ongoing operations and strategic initiatives. Investors should note the ongoing regulatory landscape and the company's proactive approach to managing evolving healthcare policies and market dynamics.